Tags : Competitive Marketplace for Biosimilars

The US FDA and FTC Sign Agreement to Support the

The partnership will address the false and misleading promotion about biosimilars within their respective authorities and prevent anti-competitive behavior. Additionally, the agencies will collaborate with participants from industry, academia and government agencies for discussing issues related to competition in the biologics market The agencies will collaboratively exchange the information for suitable practices in preventing the […]Read More